Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep215 | Calcium and Bone | ECE2023

Short-term treatment with 2000IU of cholecalciferol in patients with secondary hyperparathyroidism due to vitamin d insufficiency

Angelopoulos Nikolaos , Boniakos Anastasios , Karras Spyridon , Paparodis Rodis , Livadas Sarantis

Introduction: Conventional treatment of secondary hyperparathyroidism (SHP) requires supplementation of vitamin d analogues combined with calcium however several studies have reported concerns regarding the safety of calcium supplements particularly in the long term. If vitamin d without concomitant calcium supplementation is sufficient to prompt a fall in the parathyroid hormone (PTH) is still not known with certainty. The purpose of our study was to investigate if vitamin d ...

ea0081p232 | Thyroid | ECE2022

Levothyroxine Replacement Therapy overuse. Factors suggesting treatment discontinuation

Livadas Sarantis , Bothou Christina , Paparodis Rodis , Androulakis Ioannis , Angelopoulos Nicholas , Boniakos Anastasios , Anagnostis Panagiotis , Duntas Leonidas

Background: Levothyroxine (LT4-Rx) is one of the most prescribed drugs worldwide and the vast majority of patients receive long-term treatment. However, in a recent study of 291 subjects we found that 60% of this cohort were euthyroid two months after LT4-Rx discontinuation1.Aim of the study: A prospective clinical cohort follow-up study was carried out. In 688 subjects (82% females) aged 48.01±15.96 (range 17-84years) with 8.59±6.98...

ea0084op-06-30 | Oral Session 6: Hypothyroidism | ETA2022

Levothyroxine replacement therapy overuse and factors guiding successful treatment discontinuation: short and long-term observation data of a large cohort

Livadas Sarantis , Androulakis Ioannis , Angelopoulos Nikolaos , Anagnostis Panagiotis , Paparodis Rodis , Boniakos Anastasios , Askitis Dimitrios , Duntas Leonidas

Background: Levothyroxine (LT4Rx) is one of the most prescribed drugs worldwide the vast majority of patients receive long-term treatment. However, in a recent study of 291 subjects, it was found that 60% were euthyroid 2 months after LT4-Rx discontinuation1.Aim of the study: A prospective clinical cohort follow-up study was carried out. In 688 subjects (82% females) aged 48.01±15.96 (range 17-84years) with 8.59±6.98 years on LT4Rx witho...

ea0090p508 | Thyroid | ECE2023

The clinical significance of low dose biotin supplements (<300μg/day) in the treatment of patients with hypothyroidism: crucial or overestimated?

Angelopoulos Nikolaos , Paparodis Rodis , Androulakis Ioannis , Boniakos Anastasios , Karras Spyridon , Livadas Sarantis

Background: In the last decade, the combination of the widespread use of streptavidin-biotin technology and biotin–containing supplements (BCS) in the daily clinical practice, have led to numerous reports of erroneous hormone immunoassay results. However, there are no studies assessing the clinical and biochemical significance of that phenomenon, when treating patients with hypothyroidism. Therefore, a prospective study was designed to investigate the potential alteration...

ea0049oc4.5 | Thyroid Disease 1 | ECE2017

Levothyroxine replacement therapy: once treatment is started, should it last indefinitely?

Livadas Sarantis , Bothou Christina , Androulakis Ioannis , Boniakos Anastasios , Angelopoulos Nicholas , Duntas Leonidas

Background: Levothyroxine (LT4) is one of the most prescribed drugs worldwide. Once started, about 90% of patients continue LT4 treatment long-term.Aim of the study: To evaluate the necessity of long-term thyroxine supplementation and to determine the prognostic factors that could identify which patients may discontinue LT4 treatment.Design and methods: LT4 replacement therapy was paused for at least six weeks in all patients conse...

ea0099rc8.5 | Rapid Communications 8: Thyroid | Part II | ECE2024

Color Doppler ultrasound and real-time elastography in patients with hypothyroidism for the prediction of levothyroxine replacement: A cross-sectional study of 338 patients

Angelopoulos Nikolaos , Paparodis Rodis , Livadas Sarantis , Boniakos Anastasios , Androulakis Ioannis , Iakovou Ioannis

Aims: While hormonal assays are commonly used for thyroid function assessment, Doppler sonography provides valuable information on vascularization and blood flow. This study aimed to examine the potential associations between Doppler parameters and clinical characteristics of hypothyroid patients, such as the autoimmune nature of the disease and adequacy of LT4 replacement.Methods: A total of 338 patients with hypothyroidism, primarily caused by autoimmu...

ea0099rc8.1 | Rapid Communications 8: Thyroid | Part II | ECE2024

The role of preexisting diabetes mellitus on the risk for aggressive thyroid cancers

Paparodis Rodis , Bantouna Dimitra , Livadas Sarantis , Angelopoulos Nicholas , Androulakis Ioannis , Simeakis George , Zianni Dimitra , Perogamvros Ilias , Boniakos Anastasios , Rizoulis Andreas , Jaume Juan Carlos , Karvounis Evaggelos , Kapezanou Aikaterini , Askitis Dimitrios

Introduction: Multiple cancers have been described more commonly in patients with diabetes, and some exhibit increased aggressiveness of the tumor as well. This association has been debated with regard to thyroid cancer. With this work, we aim to clarify whether type 2 diabetes (DM2) or autoimmunity-related diabetes (type 1 diabetes+LADA=DM1) could coexist with thyroid cancers more aggressive as compared to those found in unaffected (non-DM) individuals....

ea0099p155 | Thyroid | ECE2024

Low TPO-antibody titers appear to promote aggressive thyroid cancers tumorigenesis: analysis of a large multinational dataset

Paparodis Rodis , Karvounis Evaggelos , Kapezanou Aikaterini , Bantouna Dimitra , Livadas Sarantis , Simeakis George , Askitis Dimitrios , Androulakis Ioannis , Angelopoulos Nicholas , Zianni Dimitra , Perogamvros Ilias , Boniakos Anastasios , Rizoulis Andreas , Imam Shanawaz , Carlos Jaume Juan

Introduction: In the thyroid gland, humoral immunity manifests with thyroid peroxidase (TPO) antibodies. In our studies, when TPO concentrations increased, thyroid cancers of follicular origin (TCFO) tended to develop less frequently.1 Other studies, though, reported an opposite trend in less aggressive cancers. The present work was designed to characterize the differential role of TPO antibodies in aggressive forms of TCFO (AGG) as compared to non-aggressive (NAG) ...